The ability to quantify the activity of membrane bound VEGFA in addition to soluble VEGF as shown herein may facilitate a better understanding of the action of bevacizumab on tumor-induced vascularization in both gynecologic and neurologic tumors. The gene discussed is VEGFA; the disease is neoplasm.